No abstract available
Keywords:
CKD; MRA chronic kidney disease; SGLT2i; delay; evidence; progression.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiotensin Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Benzhydryl Compounds / therapeutic use*
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetic Nephropathies / drug therapy
-
Disease Progression
-
Drug Therapy, Combination
-
Glucosides / therapeutic use*
-
Humans
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Renal Insufficiency, Chronic / drug therapy*
-
Renal Insufficiency, Chronic / physiopathology
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Benzhydryl Compounds
-
Glucosides
-
Mineralocorticoid Receptor Antagonists
-
Sodium-Glucose Transporter 2 Inhibitors
-
dapagliflozin